Spread of prostate carcinoma to the perirectal lymph node basin: Analysis of 112 rectal resections over a 10-year span for primary rectal adenocarcinoma

American Journal of Surgical Pathology

Volumn 28, Issue 9, 2004, Pages 1154-1162

  Murray, Shawn K ^a,b,c   Breau, Rodney H ^b   Guha, Ashim K ^a,b   Gupta, Rekha ^a,b  

^a Capital Health ^*  (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

^c Capital Health   (Canada)

Author keywords

Perirectal lymph nodes; Prostate carcinoma; Rectal adenocarcinoma; Staging

Indexed keywords

ACID PHOSPHATASE PROSTATE ISOENZYME; ANTIANDROGEN; CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 20; CYTOKERATIN 7; MUCIN; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BONE METASTASIS; BONE SCINTISCANNING; CANCER MORTALITY; CANCER SCREENING; CLINICAL ARTICLE; DIFFERENTIAL DIAGNOSIS; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; ORCHIECTOMY; PERIRECTAL LYMPH NODE; PROSTATE CARCINOMA; RECTUM ABDOMINOPERINEAL RESECTION; RECTUM CARCINOMA; RECTUM RESECTION; RETROSPECTIVE STUDY; STAINING;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; HUMANS; LYMPHATIC METASTASIS; MALE; PROSTATIC NEOPLASMS; RECTAL NEOPLASMS; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 4344707993     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pas.0000131543.80147.3d     Document Type: Article

References (64)

1. American Joint Committee on Cancer. In: American Joint Committee on Cancer Staging Manual, 6th ed. Chicago: Springer-Verlag; 2002.
2. Babaian RJ, Troncoso P, Bhadkamkar VA, et al. Analysis of clinicopathologic factors predicting outcome after radical prostatectomy. Cancer. 2001;91:1414-1422.
3. Bader P, Burkhard FC, Markwalder R, et al. Disease progression and survival of patients with positive lymph nodes after radical prostatectomy: is there a chance of cure? J Urol. 2003;169:849-854.
4. Ben-Izhak O, Lichtig C. Signet-ring cell carcinoma of the prostate mimicking primary gastric carcinoma. J Clin Pathol. 1992;45:452-455.
5. Blute ML, Bostwick DG, Seay TM, et al. Pathologic classification of prostate carcinoma: the impact of margin status. Cancer. 1998;82:902-908.
6. Bostwick DG, Kindrachuck RW, Rouse RV. Prostatic adenocarcinoma with endometrioid features. Am J Surg Pathol. 1985;9:595-609.
7. Bowrey DJ, Otter MI, Billins PJ. Rectal infiltration by prostatic adenocarcinoma: report on six patients and review of the literature. Ann R Coll Surg Engl. 2003;85:382-385.
8. Cheisura-Corona M, Muzzio PC, Giust G, et al. Rectal cancer: CT local staging with histopathologic correlation. Abdom Imaging. 2001;26:134-138.
9. Chen TF, Eardley I, Doyle PT, et al. Rectal obstruction secondary to carcinoma of the prostate treated by transanal resection of the prostate. Br J Urol. 1992;70:643-647.
10. Cheng L, Bergstralh EJ, Cheville JC, et al. Cancer volume of lymph node metastasis predicts progression in prostate cancer. Am J Surg Pathol. 1998;22:1491-1500.
11. Cheng L, Darson MF, Bergstralh EJ, et al. Correlation of margin status and extraprostatic extension with progression of prostate carcinoma. Cancer. 1999;86:1775-1782.
12. Cooper JH, Durning RG. An improved histochemical method for distinguishing colonic acetylsialomucin from other epithelial mucins. J Histochem Cytochem. 1981;29:1445-1447.
13. Cristallini EG, Bolis GB, Francucci M. Diagnosis of thyroid metastasis of colonic adenocarcinoma by fine needle aspiration biopsy. Acta Cytol. 1990;34:363-365.
14. Culkin DJ, Demos TC, Wheeler JS, et al. Separate annular strictures of the rectosigmoid colon secondary to unsuspected prostate cancer. J Surg Oncol. 1990;43:189-192.
15. D'Amico AV, Whittington R, Kaplan I, et al. Calculated prostate carcinoma volume: the optimal predictor of 3-year prostate specific antigen (PSA) failure free survival after surgery or radiation therapy of patients with pretreatment PSA levels of 4-20 nanograms per milliliter. Cancer. 1998;82:334-341.
16. Epstein JI, Lieberman PH. Mucinous adenocarcinoma of the prostate gland. Am J Surg Pathol. 1985;9:299-304.
17. Epstein JI, Woodruff JM. Adenocarcinoma of the prostate with endometrioid features: a light microscopic and immunohistochemical study of 10 cases. Cancer. 1986;57:111-119.
18. Epstein JL. Pathology of prostatic intraepithelial neoplasia and adenocarcinoma of the prostate: prognostic influences of stage, tumor volume, grade, and margins of resection. Semin Oncol. 1994;21:527-541.
19. Epstein JL, Carmichael M, Partin AW, et al. Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of follow-up. J Urol. 1993;149:1478-1481.
20. Epstein JL, Partin AW, Potter SR, et al. Adenocarcinoma of the prostate invading the seminal vesicle: prognostic stratification based on pathologic parameters. Urol. 2000;56:283-288.
21. Feuer JA, Lush RM, Venzon D, et al. Elevated carcinoembryonic antigen in patients with androgen-independent prostate cancer. J Invest Med. 1998;46:66-72.
22. Flint A, Lloyd RV. Pulmonary metastases of colonic carcinoma: distinction from pulmonary adenocarcinoma. Arch Pathol Lab Med. 1992;116: 39-42.
23. Fukuda H, Yamada T, Kamata S, et al. Anatomic distribution of intraprostatic lymphatics: implications for the lymphatic spread of prostate cancer - a preliminary study. Prostate. 2000;44:322-327.
24. Gagliardi G, Bayar S, Smith R, et al. Preoperative staging of rectal cancer using magnetic resonance imaging with external phase-arrayed coils. Arch Surg. 2002;137:447-451.
25. Goldstein NS. Immunophenotypic characterization of 225 prostate adenocarcinomas with intermediate or high Gleason scores. Am J Clin Pathol. 2002;117:471-477.
26. Golimbu M, Morales P, Al-Askari S, et al. Extended pelvic lymphadenectomy for prostate cancer. J Urol. 1979;121:617-620.
27. Gupta RK. Immunoreactivity of prostate-specific antigen in male breast carcinomas: two examples of a diagnostic pitfall in discriminating a primary breast cancer from metastatic prostate carcinoma. Diagn Cytopathol. 1999;21:167-169.
28. Guthman DA, Farrow GM, Myers RP, et al. Adenocarcinoma of the prostate involving 2 cell types (prostatic specific antigen producing and carcinoembryonic antigen producing) with selective metastatic spread. J Urol. 1991;146:854-856.
29. Haboubi NY, Clark P, Kaftan SM, et al. The importance of combining xylene clearance and immunohistochemistry in the accurate staging of colorectal carcinoma. J R Soc Med. 1992;85:386-388.
30. Heindenreich A, Vargar Z, Von Knobloch R. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis. J Urol. 2002;167:1681-1686.
31. Herrera L, Villarreal JR. Incidence of metastases from rectal adenocarcinoma in small lymph nodes detected by a clearing technique. Dis Colon Rectum. 1992;35:783-788.
32. Hida J, Yasutomi M, Tokoro T, et al. Examination of nodal metastases by a clearing method supports pelvic plexus preservation in rectal cancer surgery. Dis Colon Rectum. 1999;42:510-514.
33. Hulsmans FH, Bosma A, Mulder PJ, et al. Perirectal lymph nodes in rectal cancer: in vitro correlation of sonographic parameters and histopathologic findings. Radiol. 1992;184:553-560.
34. Humphrey PA. Variants of Prostatic Carcinoma in Prostate Pathology. Chicago: ASCP; 2003.
35. Kern WH, Schweizer CW. Sputum cytology of metastatic carcinoma of the lung. Acta Cytol. 1976;20:514-520.
36. Kodama S, Itoh H, Ide H, et al. Carcinoembryonic antigen and carbohydrate antigen 19-9-producing adenocarcinoma of the prostate: report of an autopsy case. Urol Int. 1999;63:193-197.
37. Kothari PS, Scardino PT, Ohori M, et al. Incidence, location, and significance of periprostatic and periseminal vesicle lymph nodes in prostate cancer. Am J Surg Pathol. 2001;25:1429-1432.
38. Lee KR, Young RH. The distinction between primary and metastatic mucinous carcinomas of the ovary: gross and histologic findings in 50 cases. Am J Surg Pathol. 2003;27:281-292.
39. McDowell GC, Johnson JW, Tenney DM, et al. Pelvic lymphadenectomy for staging clinically localized prostate cancer. Indications, complications, and results in 217 cases. Urol. 1990;35:476-482.
40. McLaughlin AP, Saltzstein SL, McCullough DL, et al. Prostatic carcinoma: incidence and location of unsuspected lymphatic metastases. J Urol. 1976;115:89-94.
41. McNeal JE. Origin and development of carcinoma in the prostate. Cancer. 1969;23:24-34.
42. McNeal JE. Regional morphology and pathology of the prostate. Am J Clin Pathol. 1968;49:347-357.
43. McNeal JE, Alroy J, Villers A, et al. Mucinous differentiation in prostatic adenocarcinoma. Hum Pathol. 1991;22:979-988.
44. McNeal JE, Redwine EA, Freiha FS, et al. Zonal distribution of prostatic adenocarcinoma: correlation with histologic pattern and direction of spread. Am J Surg Pathol. 1988;12:897-906.
45. Mhawech P, Uchida T, Pelte MF. Immunohistochemical profile of high-grade urothelial bladder carcinoma and prostate adenocarcinoma. Hum Pathol. 2002;33:1136-1140.
46. Miller EKA, Sharma NK, Lessels AM. Ductal (endometrioid) adenocarcinoma of the prostate: a clinicopathologic study of 16 cases. Histopathology. 1996;29:11-19.
47. Nielsen MB, Qvitzau S, Pedersen JF. Detection of pericolonic lymph nodes in patients with colorectal cancer: an in vitro and in vivo study of the efficacy of endosonography. AJR Am J Roentgenol. 1993;161:57-60.
48. Oxley JD, Abbot CD, Gillatt DA, Ductal carcinomas of the prostate: a clinicopathologic and immunohistochemical study. Br J Urol. 1998;81: 109-115.
49. Petrovich Z, Lieskovsky G, Langholz B, et al. Comparison of outcomes of radical prostatectomy with and without adjuvant pelvic irradiation in patients with pathologic stage C (T3N0) adenocarcinoma of the prostate. Am J Clin Oncol. 1999;22:323-331.
50. Ro JY, El-Naggar A, Ayala AG. Signet ring cell carcinoma of the prostate: electron-microscopic and immunohistochemical studies of eight cases. Am J Surg Pathol. 1988;12:453-460.
51. Ro JY, Grignon DJ, Ayala AG. Mucinous adenocarcinoma of the prostate: immunohistochemical studies. Hum Pathol. 1990;21:593-600.
52. Sanchez W, Luna-Perez P, Alvarado I, et al. Modified clearing technique to identify lymph node metastases in post-irradiated surgical specimens from rectal adenocarcinoma. Arch Med Res. 1996;27:31-36.
53. Sodee DB, Malguria N, Faulhaber P, et al. Multicenter ProstaScint imaging findings in 2154 patients with prostate cancer: the ProstaScint Imaging Centers. Urology. 2000;56:988-993.
54. Sofer M, Savoie M, Kim SS, et al. Biochemical and pathologic predictors of the recurrence of prostatic adenocarcinoma with seminal vesicle invasion. J Urol. 2003;169:153-156.
55. Terris MK, Wren SM. Results of a screening program for prostate cancer in patients scheduled for abdominoperineal resection for colorectal pathologic findings. Urology. 2001;57:943-945.
56. Theodorescu D, Frierson HFJ, Sikes RA. Molecular determination of surgical margins using fossa biopsies at radical prostatectomy. J Urol. 1999; 161:1442-1448.
57. Torbenson M, Dhir R, Nangia A. Prostatic carcinoma with signet ring cells: a clinicopathologic and immunohistochemcial analysis of 13 cases, with review of the literature. Mod Pathol. 1998;11:552-559.
58. Torricelli P, Lo Russo S, Pecchi A, et al. Endorectal coil MRI in local staging of rectal cancer. Radiol Med (Torino). 2002;103(1-2):74-83.
59. Walsh PC, Retik AB, Vaughan ED, et al. Campbell's Urology. 7th ed. Philadelphia: Saunders; 1998.
60. Wawroschek F, Vogt H, Weckermann D, et al. Radioisotope guided pelvic lymph node dissection for prostate cancer. J Urol. 2001;166:1715-1719.
61. Wawroschek F, Vogt H, Weckermann D, et al. The sentinel lymph node concept in prostate cancer: first results of gamma probe guided sentinel lymph node identification. Eur Urol. 1999;36:595-600.
62. Wheeler TM, Dillioglugil O, Kattan MW, et al. Clinical and pathological significance of the level and extent of capsular invasion in clinical stage T1-2 prostate cancer. Hum Pathol. 1998;29:856-862.
63. Woodward TA, Menke DM, Buskirk SJ. Solitary pelvic nodule: diagnosis of metastatic prostate cancer by endoscopic ultrasound-guided, fine-needle aspiration. Am J Gastroenterol. 2000;95:2372-2373.
64. Zaloudek C, Williams JW, Kempson RL. 'Endometrial' adenocarcinoma of the prostate: a distinctive tumor of probable prostatic ductal origin. Cancer. 1976;37:2255-2262.